The prognostic value of the neutrophil‑to‑platelet ratio for predicting postoperative sepsis complications after ureteroscopic lithotripsy

中性粒细胞与血小板比值对预测输尿管镜碎石术后脓毒症并发症的预后价值

阅读:1

Abstract

BACKGROUND: Sepsis is a leading cause of mortality following ureteroscopic lithotripsy (URSL). Current diagnostic criteria, such as the Sequential Organ Failure Assessment (SOFA) score, are effective for identifying established sepsis but often fail to provide early warning before clinical deterioration. This creates a critical need for readily available predictive biomarkers. Given that a rise in neutrophils and a fall in platelets are central to sepsis pathophysiology, neutrophil-to-platelet ratio (NPR) represents a promising candidate for early risk stratification. This study aimed to evaluate the NPR for the early prediction of postoperative sepsis following URSL. METHODS: We retrospectively analyzed data from 674 patients undergoing URSL (January-December 2024). After screening, 385 patients were included and classified into sepsis (n=40) and control (n=345) groups based on postoperative urine culture and SOFA score. Biomarkers measured 3-hour postoperatively were analyzed using logistic regression. Diagnostic performance was assessed by receiver operating characteristic (ROC) curves. RESULTS: Multivariable analysis identified NPR, monocyte-to-lymphocyte ratio (MLR), and female gender as independent predictors of sepsis. Among these, NPR demonstrated the strongest association. The sepsis group exhibited a significantly higher NPR (0.081±0.051 vs. 0.020±0.013, P<0.01). NPR showed robust diagnostic efficacy with an area under the curve (AUC) of 0.89 [95% confidence interval (CI): 0.838-0.955], sensitivity of 80.0%, and specificity of 88.4% at an optimal threshold of >2.77×10(-2). CONCLUSIONS: The NPR, obtained from a routine blood count 3-hour after URSL, is a strong independent predictor of subsequent sepsis, showing high diagnostic accuracy. These findings highlight its potential clinical utility for early risk stratification, pending validation in prospective multicenter cohorts.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。